GoAI
Get started
Viatris Inc. logo

Viatris Inc.

VTRS

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

$16.31

Market data unavailable

Aug 21, 3:55 PM ET

VTRS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

72

Undervalued

Momentum

59

Neutral

Sentiment

60

Mixed

Risk resilience

76

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
US

Market position

Volume
6.49M
Market cap
19.01B USD

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends48%22%-5%-31%Gross margin, FY2021: 31.17%Gross margin, FY2022: 39.95%Gross margin, FY2023: 41.74%Gross margin, FY2024: 38.15%Gross margin, FY2025: 35.06%Operating margin, FY2021: -0.19%Operating margin, FY2022: 9.93%Operating margin, FY2023: 4.97%Operating margin, FY2024: 0.07%Operating margin, FY2025: -18.62%Net margin, FY2021: -7.10%Net margin, FY2022: 12.78%Net margin, FY2023: 0.35%Net margin, FY2024: -4.30%Net margin, FY2025: -24.58%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 31.17%. Gross margin FY2022 39.95%. Gross margin FY2023 41.74%. Gross margin FY2024 38.15%. Gross margin FY2025 35.06%. Operating margin FY2021 -0.19%. Operating margin FY2022 9.93%. Operating margin FY2023 4.97%. Operating margin FY2024 0.07%. Operating margin FY2025 -18.62%. Net margin FY2021 -7.10%. Net margin FY2022 12.78%. Net margin FY2023 0.35%. Net margin FY2024 -4.30%. Net margin FY2025 -24.58%.

Income trends

Revenue

14.3B USD-2.98%

Operating income

−2.66B USD−2.67B USD

Net income

−3.51B USD-454.23%
Income trends across reported periods20.03B USD11.47B USD2.91B USD−5.66B USDRevenue, FY2021: 17.89B USDRevenue, FY2022: 16.26B USDRevenue, FY2023: 15.43B USDRevenue, FY2024: 14.74B USDRevenue, FY2025: 14.3B USDOperating income, FY2021: −34M USDOperating income, FY2022: 1.61B USDOperating income, FY2023: 766.2M USDOperating income, FY2024: 10.1M USDOperating income, FY2025: −2.66B USDNet income, FY2021: −1.27B USDNet income, FY2022: 2.08B USDNet income, FY2023: 54.7M USDNet income, FY2024: −634.2M USDNet income, FY2025: −3.51B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 17.89B USD. Revenue FY2022 16.26B USD. Revenue FY2023 15.43B USD. Revenue FY2024 14.74B USD. Revenue FY2025 14.3B USD. Operating income FY2021 −34M USD. Operating income FY2022 1.61B USD. Operating income FY2023 766.2M USD. Operating income FY2024 10.1M USD. Operating income FY2025 −2.66B USD. Net income FY2021 −1.27B USD. Net income FY2022 2.08B USD. Net income FY2023 54.7M USD. Net income FY2024 −634.2M USD. Net income FY2025 −3.51B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue14.3B USD14.74B USD15.43B USD16.26B USD17.89B USD
Cost of goods sold9.29B USD9.12B USD8.99B USD9.77B USD12.31B USD
Gross profit5.01B USD5.62B USD6.44B USD6.5B USD5.58B USD
Research and development965.9M USD808.7M USD805.2M USD662.2M USD681M USD
Selling, general, and administrative3.79B USD4.43B USD4.65B USD4.18B USD4.53B USD
Operating expenses7.68B USD5.61B USD5.67B USD4.88B USD5.61B USD
Interest expense471.3M USD550M USD573.1M USD592.4M USD636.2M USD
Depreciation and amortization2.8B USD2.89B USD2.74B USD3.03B USD4.51B USD
Operating income−2.66B USD10.1M USD766.2M USD1.61B USD−34M USD
Net income−3.51B USD−634.2M USD54.7M USD2.08B USD−1.27B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 3 misses, 0 met estimates
Average EPS surprise
+4.75%
11 comparable reports
Latest EPS result
0.69
Estimate 0.6 · Beat by 14.81%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.730.640.540.45Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.54, estimate 0.61, surprise -11.48%, Miss. Q2 2025, reported May 8, 2025: actual 0.5, estimate 0.492, surprise +1.65%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.62, estimate 0.556, surprise +11.51%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.67, estimate 0.621, surprise +7.89%, Beat. Q1 2026, reported Feb 26, 2026: actual 0.57, estimate 0.532, surprise +7.14%, Beat. Q2 2026, reported May 7, 2026: actual 0.59, estimate 0.502, surprise +17.53%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.69, estimate 0.601, surprise +14.81%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.67, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.96B3.67B3.38B3.08BQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 3.53B USD, estimate 3.6B USD, surprise -2.00%, Miss. Q2 2025, reported May 8, 2025: actual 3.25B USD, estimate 3.24B USD, surprise +0.59%, Beat. Q3 2025, reported Aug 7, 2025: actual 3.58B USD, estimate 3.47B USD, surprise +3.32%, Beat. Q4 2025, reported Nov 6, 2025: actual 3.76B USD, estimate 3.62B USD, surprise +3.76%, Beat. Q1 2026, reported Feb 26, 2026: actual 3.7B USD, estimate 3.53B USD, surprise +4.85%, Beat. Q2 2026, reported May 7, 2026: actual 3.52B USD, estimate 3.36B USD, surprise +4.77%, Beat. Q3 2026, reported Aug 6, 2026: actual 3.76B USD, estimate 3.68B USD, surprise +2.21%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 3.81B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$21.00

28.68% upside
Past 12 months12-month forecastHigh $22.00Average $21.00Low $20.00

Rating distribution

13 ratings
Strong buy00%
Buy431%
Hold862%
Sell18%
Strong sell00%

Recent analyst actions

7 institutions
Truist SecuritiesmaintainBuy
JP MorganmaintainNeutral
Argus ResearchupgradeHoldBuy
JefferiesmaintainBuy

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.48

2025 complete year+100.0% since 2006

2026 partial: $0.36

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Aug 21, 2026

$0.12

Quarterly

Record Aug 21, 2026 · Payment Sep 16, 2026

Dividend

Ex-dividend May 22, 2026

$0.12

Quarterly

Record May 22, 2026 · Payment Jun 17, 2026

Dividend

Ex-dividend Mar 9, 2026

$0.12

Quarterly

Record Mar 9, 2026 · Payment Mar 18, 2026

Dividend

Ex-dividend Nov 24, 2025

$0.12

Quarterly

Record Nov 24, 2025 · Payment Dec 15, 2025

Dividend

Ex-dividend Aug 22, 2025

$0.12

Quarterly

Record Aug 22, 2025 · Payment Sep 15, 2025

Dividend

Ex-dividend May 23, 2025

$0.12

Quarterly

Record May 23, 2025 · Payment Jun 16, 2025

VTRS peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding VTRS

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
651.56M
Weight
0.03%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
536.92M
Weight
0.03%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
470.07M
Weight
0.25%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETF logoVanguard Morningstar Small-Cap Value ETFVBR
Market value
298.59M
Weight
0.43%
AUM
68.3B USD
Expense ratio
0.05%
Price / 1D
$249.18+0.68%
iShares Core S&P 500 ETF logoiShares Core S&P 500 ETFIVV
Market value
253.03M
Weight
0.03%
AUM
891.84B USD
Expense ratio
0.03%
Price / 1D
$769.31+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
231.49M
Weight
0.03%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
Invesco S&P 500 Equal Weight ETF logoInvesco S&P 500 Equal Weight ETFRSP
Market value
190.93M
Weight
0.19%
AUM
100.27B USD
Expense ratio
0.20%
Price / 1D
$221.67+0.63%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
134.03M
Weight
0.30%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%

Continue in GoAI

Research VTRS

research.disclaimer